Prostate cancer: Three drug trials to watch

Today (19 November) marks International Men’s Day with the theme for 2024 being Men’s Health Champions, shining a light on the problems of men’s health and the people at the heart of delivering the solution.

There are several candidates under investigation for prostate cancer for patients at various stages of the disease including an oncolytic virus, PARP inhibitor and EZH2 inhibitor.